Injective INJ
Current Price
$3.26 +0.08%
$0.1900 Daily Range (5.83%)
$3.15$3.34
$55.01M Daily Volume
795 BTC
Vol/MktCap: 16.90%
Market Performance
0.08% Relative BTC Volume
The total volume of Injective is $55.01M over the past 24 hours, compared to $65.87B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.29 -0.91%
13 SMA $3.26 +0.08%
21 SMA $3.25 +0.42%
55 SMA $3.19 +2.29%
144 SMA $3.43 -4.95%
Price Performance
-1.06% 1 Hour Change
$3.26 from $3.29
-10.43% 7 Day Change
-$0.3399 from $3.60
-27.92% 14 Day Change
-$0.9103 from $4.17
-36.82% 30 Day Change
-$1.20 from $4.46
All Time High
March 14, 2024
$52.62 -93.80%
-$49.36 vs. now
24H Change
276.25K USD +0.08%
4 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
16.95M INJ
traded over past 24 hours
16.95% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.28, reflecting a modest 24-hour change of 0.89%. The daily trading range has been tight, with a high of $3.34 and a low of $3.15, indicating limited volatility in recent sessions.
Volume stands at 56,125,000, which constitutes 17.12% of the market cap, suggesting active trading participation. The short-term moving averages show a mixed sentiment, with the 8-hour SMA at $3.29 indicating a slight downward trend, while the 13-hour and 21-hour SMAs show positive momentum.
The 1-hour RSI is at 67, indicating that INJ is approaching overbought territory, which could imply a short-term pullback. In contrast, the 7-day RSI at 47 suggests a more neutral stance over a longer timeframe, reflecting a lack of strong buying or selling pressure.
From a longer-term perspective, INJ has faced significant price declines, with a 7-day change of -9.83%, a 14-day change of -28.00%, and a 30-day decline of -36.82%. This sustained downtrend emphasizes the need for caution, as the market sentiment remains bearish over these periods.
Injective's all-time high of $52.62, reached in March 2024, underscores the potential upside; however, the current price reflects a substantial retracement from this level. Given the recent performance and technical indicators, the asset shows potential for short-term gains, but long-term weakness cannot be overlooked.
In conclusion, I rate INJ as a Hold. While there may be opportunities for short-term trading given the current price action, the overall trend remains bearish, and caution is advised for longer-term positions.
Volume stands at 56,125,000, which constitutes 17.12% of the market cap, suggesting active trading participation. The short-term moving averages show a mixed sentiment, with the 8-hour SMA at $3.29 indicating a slight downward trend, while the 13-hour and 21-hour SMAs show positive momentum.
The 1-hour RSI is at 67, indicating that INJ is approaching overbought territory, which could imply a short-term pullback. In contrast, the 7-day RSI at 47 suggests a more neutral stance over a longer timeframe, reflecting a lack of strong buying or selling pressure.
From a longer-term perspective, INJ has faced significant price declines, with a 7-day change of -9.83%, a 14-day change of -28.00%, and a 30-day decline of -36.82%. This sustained downtrend emphasizes the need for caution, as the market sentiment remains bearish over these periods.
Injective's all-time high of $52.62, reached in March 2024, underscores the potential upside; however, the current price reflects a substantial retracement from this level. Given the recent performance and technical indicators, the asset shows potential for short-term gains, but long-term weakness cannot be overlooked.
In conclusion, I rate INJ as a Hold. While there may be opportunities for short-term trading given the current price action, the overall trend remains bearish, and caution is advised for longer-term positions.
Updated 103 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Binance trading data reveals why Bitcoin prices are sliding even as spot buyers flood the market with bids
Bitcoin’s hard cap is easy to understand: there will only ever be 21 million coins.

21Shares ONDO ETF filing sparks attention, but will it help its price?
Weak structure and defensive positioning will continue to limit upside conviction.

LEO’s 17% uptick – Traders, is this real conviction or beta chasing?
LEO’s rally revealed growing intent, but conviction still faces a decisive structural test.

California Man Allegedly Masterminds $37,000,000 Ponzi Scheme, Draining Trove of Cash From More than 100 Victims’ Bank Accounts: SEC
The U.S. Securities and Exchange Commission (SEC) is accusing a California entrepreneur and his companies of executing a multi-million dollar Ponzi scheme.